🇺🇸 FDA
Patent

US 10835513

Methods and treatments for the learning and memory deficits associated with Noonan syndrome

granted A61KA61K31/22A61K31/277

Quick answer

US patent 10835513 (Methods and treatments for the learning and memory deficits associated with Noonan syndrome) held by The Regents of the University of California expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/22, A61K31/277, A61K31/366, A61K31/40